TYR and melanoma: Gismondi et al. are also found that nimesulide, a non-steroidal anti-inflammatory drug, played as an antineoplastic agent to induce B16-F10 melanoma cell differentiation by enhancing the transglutaminase and tyrosinase activity and increase of melanin production [34].